Surgery News and Research

RSS

Columbia Asia opens new hospitals in India and Malaysia

Columbia Asia, a fast-growing hospital company with Pacific Northwest roots, has opened hospitals in two cities near New Delhi, India, and Kuala Lumpur, Malaysia.

23 Dec 2010

Promising initial data from STABLE clinical trial for endovascular treatment of Type B aortic dissection

Study investigators reported positive steps in Cook Medical's efforts to gain FDA approval of the treatment assessed in the STABLE clinical trial, designed to evaluate the safety and efficacy of a proximal endograft and a distal uncovered stent for the endovascular treatment of Type B aortic dissection for purposes of seeking FDA approval. The findings were presented by Dr. Joseph Lombardi at the 37th annual VEITHsymposium.

23 Dec 2010

St. Luke’s second in nation to perform EVAR with Endurant AAA Stent Graft System

An 80-year-old patient at St. Luke's Episcopal Hospital (St. Luke's) in Houston became the second in the nation to be treated with a newly approved FDA device for an abdominal aortic aneurysm (AAA). The condition, often called, "the silent killer," is a dangerous bulge or ballooning in the main artery of the body that typically causes no symptoms until it ruptures.

23 Dec 2010

Northstar Healthcare reports successful syndication of MicroSurgery Institute of Houston

Northstar Healthcare Inc. today announced the successful syndication of its newly formed operating partnership MicroSurgery Institute of Houston ("MSI") with an initial seven physician partners. Northstar will participate in the MSI partnership by leasing the surgery center assets and staff of The Palladium for Surgery - Houston, Ltd. partnership ("Palladium") to MSI for an ownership interest of 25%.

23 Dec 2010

Certain drugs may block tumor host interactions but do not destroy cancer cells

A class of drugs thought to kill cancer cells may in fact block "cross talk" between the cancer cell and normal immune cells, resulting in reduced cancer growth and spread-a discovery that could significantly alter the way cancer drugs are evaluated in the future.

23 Dec 2010

New study reveals statin therapy linked to reduced postoperative mortality

Statin drugs were first introduced to lower blood cholesterol concentrations; however, research is now discovering other benefits. A new study from France, published in the January 2011 issue of Anesthesiology, is the first to analyze the impact of preoperative chronic statin therapy on postoperative adverse events in surgical patients. Findings from the study suggest that statin therapy is associated with reduced postoperative mortality.

23 Dec 2010

Photon-based radiation therapy may result in better survival rate in patients with spinal-cord tumor

A study comparing the long-term outcomes of patients with spinal-cord tumors following radiation therapy suggests that certain subsets of patients have better long-term survival.

23 Dec 2010

FDA approves Gardasil for prevention of anal cancer

The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.

23 Dec 2010

Snowblowers can cause severe hand injuries during winter

It's the peak season for snowstorms, and snowblowers are working overtime. But Loyola University Health System hand surgeon Dr. Randy Bindra cautions that snowblowers can cause severe hand injuries, including loss of fingers that can require one or more surgeries and months of rehabilitation.

22 Dec 2010

Top ten advances in cardiovascular, stroke research in 2010

Research on reducing risks, improving medical treatment and improving lifestyle behaviors to fight the battle against heart disease and stroke are among the key scientific findings that make up this year's top cardiovascular and stroke research recognized by the American Heart Association/American Stroke Association.

22 Dec 2010

$Emory University study reaffirms benefits of VNS Therapy System for refractory epilepsy$

Emory University study reaffirms benefits of VNS Therapy System for refractory epilepsy

Cyberonics, Inc. announced today that the VNS Therapy System, the only FDA-approved implantable medical device for the treatment of refractory epilepsy, was featured in 22 poster presentations and in the Plenary II session on neurostimulation at the annual American Epilepsy Society Meeting that took place recently in San Antonio, Texas.

22 Dec 2010

First implantation of Medtronic Transcatheter Aortic Valve Prosthesis in US performed at Mount Sinai

David H. Adams, MD, Marie-Jos-e and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery, Samin K. Sharma, MD, the Zena and Michael A. Weiner Professor and Director of the Cardiac Catheterization Laboratory, and Annapoorna S. Kini, MD, Associate Professor and Associate Director of the Cardiac Catheterization Laboratory at The Mount Sinai Medical Center, have performed the first implantation of the Medtronic CoreValve- Transcatheter Aortic Valve Prosthesis in the United States.

22 Dec 2010

Researchers receive $100,000 NFL grant to study tissue engineering for spinal injuries

Researchers from Cornell University and Weill Cornell Medical College have been awarded $100,000 by NFL Charities, the charitable foundation of the National Football League owners, to research tissue engineering for spinal injuries.

22 Dec 2010

Gold nanoparticles show great potential for tumour targeted drug delivery

The World Gold Council (WGC) is delighted with the successful phase 1 clinical trial of a unique nanomedicine that uses nanoparticles of gold as the core of a delivery system for tumour targeted drug delivery.

22 Dec 2010

U.S. pivotal clinical trial of Medtronic CoreValve begins

Medtronic, Inc. today announced the beginning of its Medtronic CoreValve® U.S. Pivotal clinical trial in the United States. The first CoreValve transcatheter aortic valve implantation (TAVI) procedure was performed by David H. Adams, M.D., and Samin K. Sharma, M.D., at The Mount Sinai Medical Center in New York City.

22 Dec 2010

Spinal Botox injection reduces pain

Botulinum neurotoxin type A (BoNT/A)—better known as Botox—reduces responses to an inflammation-related pain stimulus when injected into the spinal canal in mice, reports a study in the January issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

22 Dec 2010

Surgery News and Research

Columbia Asia opens new hospitals in India and Malaysia

Promising initial data from STABLE clinical trial for endovascular treatment of Type B aortic dissection

St. Luke’s second in nation to perform EVAR with Endurant AAA Stent Graft System

Northstar Healthcare reports successful syndication of MicroSurgery Institute of Houston

Certain drugs may block tumor host interactions but do not destroy cancer cells

New study reveals statin therapy linked to reduced postoperative mortality

Photon-based radiation therapy may result in better survival rate in patients with spinal-cord tumor

FDA approves Gardasil for prevention of anal cancer

Snowblowers can cause severe hand injuries during winter

Top ten advances in cardiovascular, stroke research in 2010

Emory University study reaffirms benefits of VNS Therapy System for refractory epilepsy

First implantation of Medtronic Transcatheter Aortic Valve Prosthesis in US performed at Mount Sinai

Researchers receive $100,000 NFL grant to study tissue engineering for spinal injuries

Gold nanoparticles show great potential for tumour targeted drug delivery

U.S. pivotal clinical trial of Medtronic CoreValve begins

Spinal Botox injection reduces pain

El Camino announces first patient implant in Medtronic CoreValve clinical trial

Men above age 75 with high-risk prostate cancer often under-treated

Moderately and morbidly obese drivers face increase risk of death during severe vehicle crashes

Wyden's cancer treatment highlights debate over health care cost vs. personal choice

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Latest News